Individualized treatment approach for adolescent scoliosis
The Individualized Stepwise Treatment Mode of Adolescent Idiopathic Scoliosis
This study is testing a new way to prevent and treat scoliosis in teenagers by using technology to create personalized treatment plans based on their specific risk factors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 76 (estimated) |
| Ages | 3 Years to 18 Years |
| Sex | All |
| Sponsor | Hangzhou Medical College Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06314594 on ClinicalTrials.gov |
What this trial studies
This project aims to develop a comprehensive prevention and treatment system for adolescent idiopathic scoliosis (AIS) by utilizing advanced mathematical methods and machine learning techniques. It focuses on creating an early warning model and a stepwise treatment model based on risk factors identified through social surveys. The study will also implement a software platform and physical devices for measuring and correcting scoliosis, integrating data management and monitoring technologies to enhance health education and intervention strategies. The goal is to shift from passive to active prevention and control of scoliosis in adolescents.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 12 to 16 diagnosed with moderate to mild AIS and a Cobb angle of less than 45°.
Not a fit: Patients with severe scoliosis, cognitive impairments, or significant organ dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve early detection and treatment of adolescent scoliosis, leading to better patient outcomes.
How similar studies have performed: While there have been studies on scoliosis treatment, this approach utilizing transfer learning and semi-supervised learning is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The diagnosis of moderate and mild AIS, with a Cobb angle measuring less than 45°; 2. The age range of 12 to 16 years old; 3. Participants are required to have no history of mental illness, possess normal communication skills, and be proficient in reading and writing; 4. Signed informed consent by the patient or their family. Exclusion Criteria: Patients who fulfill any of the following conditions will be excluded a clear history of inducement, such as diseases caused by trauma, surgery, cognitive impairment, severe dysfunction of heart, liver, kidney and other organs, and malignant tumors, immune diseases and other malignant diseases.
Where this trial is running
Hangzhou, Zhejiang
- the Affiliated Zhejiang Provincial People's Hospital to Hangzhou Medical College. — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Xinyun Dr Li, doctor — hangzhou medical colleage
- Study coordinator: Xinyun Dr LI, Doctor
- Email: lxyjasmine2010@163.com
- Phone: 8618069783240
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.